American Heart Journal
Volume 147, Issue 2 , Pages 218-223, February 2004

Interstudy reproducibility of right ventricular volumes, function, and mass with cardiovascular magnetic resonance

  • Frank Grothues, MD

      Affiliations

    • Centre for Advanced MR in Cardiology, Cardiovascular MR Unit, Royal Brompton Hospital, National Heart and Lung Institute, Imperial College, London, United Kingdom
    • Department of Cardiology, Angiology and Pneumology, Otto-von-Guericke-University Magdeburg, Magdeburg, Germany
  • ,
  • James C Moon, MD

      Affiliations

    • Centre for Advanced MR in Cardiology, Cardiovascular MR Unit, Royal Brompton Hospital, National Heart and Lung Institute, Imperial College, London, United Kingdom
  • ,
  • Nicholas G Bellenger, MD

      Affiliations

    • Centre for Advanced MR in Cardiology, Cardiovascular MR Unit, Royal Brompton Hospital, National Heart and Lung Institute, Imperial College, London, United Kingdom
  • ,
  • Gillian S Smith, BSc

      Affiliations

    • Centre for Advanced MR in Cardiology, Cardiovascular MR Unit, Royal Brompton Hospital, National Heart and Lung Institute, Imperial College, London, United Kingdom
  • ,
  • Helmut U Klein, MD

      Affiliations

    • Department of Cardiology, Angiology and Pneumology, Otto-von-Guericke-University Magdeburg, Magdeburg, Germany
  • ,
  • Dudley J Pennell, MD, FRCP, FACC

      Affiliations

    • Centre for Advanced MR in Cardiology, Cardiovascular MR Unit, Royal Brompton Hospital, National Heart and Lung Institute, Imperial College, London, United Kingdom
    • Corresponding Author InformationReprint requests: Dr Dudley J. Pennell, Professor of Cardiology, Centre for Advanced MR in Cardiology, Royal Brompton Hospital, Sydney Street, London SW36NP, UK.

Received 5 May 2003; accepted 10 October 2003.

Abstract 

Background

Cardiovascular magnetic resonance (CMR) has shown excellent results for interstudy reproducibility in the assessment of left ventricular (LV) parameters. However, interstudy reproducibility data for the more complex-shaped right ventricle in a large study group have not yet been reported. We sought to determine the interstudy reproducibility of measurements of right ventricular (RV) volumes, function, and mass with CMR and compare it with correspondent LV values.

Methods

Sixty subjects (47 men; 20 healthy volunteers, 20 patients with heart failure, 20 patients with ventricular hypertrophy) underwent 2 CMR studies for assessment of RV measurements with a minimum time interval between each study.

Results

The overall interstudy reproducibility (range between groups) for the RV was 6.2% (4.2%–7.8%) for end-diastolic volume, 14.1% (8.1%–18.1%) for end-systolic volume, 8.3% (4.3%–10.4%) for ejection fraction (EF), and 8.7% (7.8%–9.4%) for RV mass. RV reproducibility was not as good as for the LV for all measures in all 3 groups, but this was only statistically significant for EF (P <.01).

Conclusions

CMR showed good interstudy reproducibility for RV function parameters in healthy subjects, patients with heart failure, and patients with hypertrophy, which suggests that CMR is reliable for serial RV assessment. These data can be used to power sample sizes for longitudinal research studies of RV volume and function. The reproducibility values were similar to, but generally lower than, the reproducibility values for the LV in the same study population, which indicates that sample sizes for RV studies are in general larger than those for LV studies.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Supported by CORDA and the Wellcome Trust (London, UK), ADUMED Foundation (Zurich, Switzerland), GlaxoSmithKline (Harlow, UK), and the British Heart Foundation (London, UK).

PII: S0002-8703(03)00711-7

doi:10.1016/j.ahj.2003.10.005

American Heart Journal
Volume 147, Issue 2 , Pages 218-223, February 2004